A sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometry-Reference-Cited by-同舟云学术

A sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometry

Published:2011-10 Issue:28 Volume:879 Page:2984-2990
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Hendrikx Jeroen J.M.A.,Hillebrand Michel J.X.,Thijssen Bas,Rosing Hilde,Schinkel Alfred H.,Schellens Jan H.M.,Beijnen Jos H.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference36 articles.

1. Taxanes: an overview of the pharmacokinetics and pharmacodynamics

2. Preclinical Pharmacology of the Taxanes: Implications of the Differences

3. Intravenous-to-Oral Switch in Anticancer Chemotherapy: A Focus on Docetaxel and Paclitaxel

4. Modulation of oral bioavailability of anticancer drugs: from mouse to man

5. Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update;Journal of Chromatography B;2024-04

2. Pharmacokinetic analysis of placental transfer of ritonavir as a component of paxlovid using microdialysis in pregnant rats;Heliyon;2024-01

3. Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer;Cancer Chemotherapy and Pharmacology;2023-03

4. A UPLC-MS/MS Method for Plasma Biological Monitoring of Nirmatrelvir and Ritonavir in the Context of SARS-CoV-2 Infection and Application to a Case;Journal of the American Society for Mass Spectrometry;2022-09-09

5. Simultaneous Estimation of Ombitasvir, Paritaprevir and Ritonavir in Tablet Dosage Form by Reverse Phase High-Performance Liquid Chromatography;International Journal of Life Science and Pharma Research;2022-07-15